Article
Author(s):
While leaders of both political parties say they want to provide Medicare patients with meaningful coverage for prescription drug expenses, major philosophical differences threaten to make that objective extremely difficult to achieve.
Advances in HS treatment with Chris Sayed, MD
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
New Hydroquinone Pigmentation Alternatives
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Study Reveals Potential Genetic Connection Between Hidradenitis Suppurativa and Increased Risk of CAD and Diabetes
Jeff Stark, MD: Insights on the Approval of Bimekizumab for HS